<DOC>
	<DOCNO>NCT01749878</DOCNO>
	<brief_summary>Phase 1 , first-in-human , randomize , ascend single-dose , placebo-controlled , double-blind study safety , tolerability , bioeffect REGN1500</brief_summary>
	<brief_title>Study Assess Safety Tolerability Single Doses REGN1500</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>1 . Body mass index 18.0 40.0 kg/m2 , inclusive 2 . Normal standard 12lead ECG 3 . Willing refrain consumption alcohol 24 hour prior study visit 4 . Willing consistently maintain his/her usual diet duration study 5 . Willing refrain strenuous exercise duration trial 6 . Willing able comply clinic visit studyrelated procedure 7 . Provide sign informed consent 8 . For sexually active men woman , willingness utilize adequate contraception partner [ ] become pregnant full duration study . 1 . Any clinically significant abnormality observe screen visit 2 . History drug alcohol abuse within 1 year screen 3 . Receipt another investigational drug therapy within 30 day least 5 halflives ( whichever longer ) , investigational drug prior screen visit . 4 . Significant concomitant illness history significant illness cardiac , renal , neurological , endocrinological , metabolic lymphatic disease , illness condition may adversely affect subject participation study 5 . Known history human immunodeficiency virus ( HIV ) antibody ; and/or positive hepatitis B surface antigen ( HBsAg ) , and/or positive hepatitis C antibody ( HCV ) screen visit 6 . Hospitalization reason within 60 day screen 7 . History presence malignancy within 5 year prior screen visit ( successfully treat nonmetastatic cutaneous squamous cell basal cell carcinoma , and/or localize carcinoma situ cervix 8 . Any medical psychiatric condition , opinion investigator , would place subject risk , interfere participation study interfere interpretation study result 9 . Any subject investigator subinvestigator , research assistant , pharmacist , study coordinator , staff directly involve conduct protocol , family member staff involve conduct protocol 10 . Pregnant breastfeed woman ( The inclusion/ exclusion criterion provide intend contain consideration relevant patient 's potential participation clinical trial ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>